about
High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial.The role of vitamin D in regulating the iron-hepcidin-ferroportin axis in monocytes.Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.Low vitamin D concentration is not associated with increased mortality and morbidity after cardiac surgeryEffects of sun exposure and dietary vitamin D intake on serum 25-hydroxyvitamin D status in hemodialysis patientsVitamin D supplementation in pre-dialysis chronic kidney disease: A systematic review.Nutrition for diabetic retinopathy: plummeting the inevitable threat of diabetic vision loss.Relationship of vitamin D levels to blood pressure in a biethnic populationThe Association of Vitamin D Status with Dyslipidaemia and Biomarkers of Endothelial Cell Activation in Older Australians.Hypocalcemic rachitic cardiomyopathy in infants.Effects of high-dose cholecalciferol on serum markers of inflammation and immunity in patients with early chronic kidney disease.Glycated hemoglobin A1C and vitamin D and their association with diabetic retinopathy severity.Is there any correlation between vitamin D insufficiency and diabetic retinopathy?The role of vitamin D deficiency and vitamin d receptor genotypes on the degree of collateralization in patients with suspected coronary artery disease.Treatment of patients with intermediate cardiovascular risk: Are clinical measures enough?Patients with FGF23-related hypophosphatemic rickets/osteomalacia do not present with left ventricular hypertrophy.Redox State of Human Serum Albumin and Inflammatory Biomarkers in Hemodialysis Patients with Secondary Hyperparathyroidism During Oral Calcitriol Supplementation for Vitamin D
P2860
Q30524139-4A94CEFB-DF5B-4373-90A2-601E51739E51Q33993335-7B394FF4-839D-4B9C-AE4D-3EE5FD43FCC0Q34491713-E2F16347-BCF0-4D30-84E1-772A19BED57AQ34749343-67CC13BA-6D62-47C1-B2BE-5F6B93C480CAQ35308113-50B02196-0F5E-49C6-AB1D-3170CBDAC67EQ36187587-E8AE15AE-6F0A-44BA-B237-90477A4C40B2Q36297109-E5C773FC-A8F7-4AF9-8B7D-76A00680F9D3Q36467951-62F5FB86-FE2A-4929-9FC2-92E644431850Q37202630-A8D17F2B-D3CA-4B3D-A263-46D89E3CE937Q37258560-A427FB1D-8D20-4514-934B-5F975182D4B1Q37300443-B5867376-A55B-44CE-8CF5-D61A9C2C2768Q38730387-007FC3E6-A555-405F-AF86-491C43C48860Q40050054-82B809FA-9550-4045-AB18-5A55130229BAQ42115810-835EE1EB-F7DF-42A9-9288-82935E53C42BQ45125528-78757CEE-DF09-4D0F-80DB-1AC6B39F68BEQ51380599-212B3EA7-9391-4B14-84FA-EB90FD4CB69CQ59132558-21984694-23EE-498B-9EE6-49425E46F497
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Vitamin d therapy and cardiovascular health.
@en
Vitamin d therapy and cardiovascular health.
@nl
type
label
Vitamin d therapy and cardiovascular health.
@en
Vitamin d therapy and cardiovascular health.
@nl
prefLabel
Vitamin d therapy and cardiovascular health.
@en
Vitamin d therapy and cardiovascular health.
@nl
P2860
P921
P1476
Vitamin d therapy and cardiovascular health.
@en
P2093
Suzanne E Judd
P2860
P2888
P304
P356
10.1007/S11906-011-0190-2
P577
2011-06-01T00:00:00Z